A Potential New Therapeutic Approach to DMD: PKC Theta Inhibition

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2017.01.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Asthma and Poly(ADP-Ribose) Polymerase Inhibition: A New Therapeutic Approach

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

PKC-theta-mediated Signal Delivery From the TCR/CD28 Surface Receptors

Frontiers in Immunology
AllergyImmunology
2012English

Mesenchymal Stem Cell-Derived Exosomes: A New Therapeutic Approach to Osteoarthritis?

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2019English

A New Approach to Generate a Catalogue of Potential Historical Novae

Astronomische Nachrichten
AstrophysicsAstronomyPlanetary ScienceSpace
2020English

Neprilysin Inhibition: A New Therapeutic Option for Type 2 Diabetes?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Targeting theNotch Pathway: A Potential Therapeutic Approach for Desmoid Tumors

Cancer
Cancer ResearchOncology
2015English

Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

Diabetes Mellitus as a Conformational Disease: A Novel Potential Therapeutic Approach

Endocrine Abstracts
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy